16th EFMC Short Course on Medicinal Chemistry

New Opportunities in GPCR Drug Discovery

 Oegstgeest (near Leiden), The Netherlands    May 8-11, 2022

Confirmed Speakers

Discovery of H1/H4 Dual Ligands

Prof. Iwan DE ESCH
Prof. Iwan DE ESCH
VU AMSTERDAM, Amsterdam, The Netherlands
Read more

GPCR Ligand Design: Cheminformatics and Modelling

Dr Chris DE GRAAF
Dr Chris DE GRAAF
SOSEI HEPTARES, Cambridge, United Kingdom
Read more

GPCR Ligands: Molecular Recognition, Kinetics and Allosteric Modulation

Prof. Laura HEITMAN
Prof. Laura HEITMAN
UNIVERSITY OF LEIDEN, Leiden, The Netherlands
Read more

Binding and Modulating GPCRs by Inside/Outside Binding Nanobodies

Dr Raimond HEUKERS
Dr Raimond HEUKERS
QVQ, Utrecht, The Netherlands
Read more

Discovery of Cariprazine, A Dopamine D3 Receptor Prefering Third Generation Antipsychotics

Prof. György KESERU
Prof. György KESERU
HUNGARIAN ACADEMY OF SCIENCES, Budapest, Hungary
Read more

A General Introduction into GPCRdb & Hands-on with the GPCRdb

Dr Albert KOOISTRA
Dr Albert KOOISTRA
UNIVERSITY OF COPENHAGEN, København, Denmark
Read more

Partial Agonism/Biased Signalling and its Therapeutical Relevance

Dr Rob LANE
Dr Rob LANE
UNIVERSITY OF NOTTINGHAM, Nottingham, United Kingdom
Read more

General Introduction to GPCRs: Pharma Relevance, Indications, Molecular Pharmacology

Prof. Rob LEURS
Prof. Rob LEURS
VRIJE UNIVERSITEIT AMSTERDAM, Amsterdam, The Netherlands
Read more

System Biology Approaches to GPCR Targets

Dr Aurelien RIZK
Dr Aurelien RIZK
INTERAX BIOTECH, Villigen, Switzerland
Read more

Structural Biology of GPCRs in the Era of Cryo-EM – Implications for Drug Design and Discovery

Dr Moran SHALEV-BENAMI
Dr Moran SHALEV-BENAMI
WEIZMANN INSTITUTE, Rehovot, Israel
Read more